Open AccessHypopigmentation Associated With an Adenovirus-Mediated gp100/MART-1–Transduced Dendritic Cell Vaccine for Metastatic Melanoma
Author(s) -
Hensin Tsao,
Peri Millman,
Gerald P. Linette,
F. Stephen Hodi,
Arthur J. Sober,
Mark A. Goldberg,
Frank G. Haluska
Publication year - 2002
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archderm.138.6.799
Subject(s) - medicine , vitiligo , melanoma , hypopigmentation , antigen , immunology , dendritic cell , immunotherapy , cancer research , dermatology , immune system
Reports of vitiligo associated with metastases and rare cases of spontaneous regression of disease have fueled enthusiasm for immunologic approaches to the treatment of advanced melanoma. More recent strategies have focused on using antigen-presenting dendritic cells as vaccines.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom